Delayed post-hypoxic leukoencephalopathy
- Authors: Matveeva TV1, Zhukova VD1, Artemyeva AO1, Kazantsev AY.1, Gaifutdinov RT1
-
Affiliations:
- Kazan State Medical University
- Issue: Vol 100, No 6 (2019)
- Pages: 985-991
- Section: Clinical observations
- URL: https://ogarev-online.ru/kazanmedj/article/view/18523
- DOI: https://doi.org/10.17816/KMJ2019-985
- ID: 18523
Cite item
Full Text
Abstract
Delayed post-hypoxic leukoencephalopathy is a clinical syndrome caused by a lesion of the white matter of the brain with an acute onset developing several days after emerging from coma. The reason of delayed post-hypoxic leukoencephalopathy is prolonged cerebral hypooxygenation, it often results from carbon monoxide poisoning, less often it is associated with acute brain hypoxia caused by respiratory failure, an overdose of opiates. The leading role in the clinical picture of delayed post-hypoxic leukoencephalopathy is played by the duration and severity of cerebral anoxia in the acute period of the disease. The period of temporary well-being of a patient with an episode of acute hypoxia lasts 2 to 40 days. Pathogenesis and pathophysiology have not been well studied. Its development after carbon monoxide poisoning is considered to be caused by direct myelinotoxic effect. It is essential to collect a detailed history for diagnosing a case, neurovisualization is an informative method for investigation. Magnetic resonance imaging may detect the signs that are pathognomonic for delayed post-hypoxic leukoencephalopathy, that is diffuse hyperintensity of the white matter of the cerebral hemispheres in T2-mode, symmetry of the damage of both cerebral hemispheres, damage of the subcortical gray matter — globus pallidus. The standards for the treatment of delayed post-hypoxic leukoencephalopathy have not been developed. The use of glucocorticoids has been described, perspective use of amantadine were shown in case of frontal-subcortical syndrome. There are recommendations on prescribing the following therapy for the patients with delayed post-hypoxic leukoencephalopathy: hyperbaric oxygenation, coenzyme Q10, vitamin E and group B. We present a clinical observation that demonstrates the complexity of the clinical picture of delayed post-hypoxic leukoencephalopathy, the difficulty of its diagnosis without taking into account information about previous carbon monoxide poisoning. The results of magnetic resonance imaging at the onset of the disease are considered to be of utmost interest. The clinical observation of the patient presented in the article allows us to make an assumption about pathogenesis and contributes to search for means aimed at preventing the development of delayed post-hypoxic leukoencephalopathy in people with acute carbon monoxide poisoning.
Full Text
##article.viewOnOriginalSite##About the authors
T V Matveeva
Kazan State Medical University
Email: valyazhu@gmail.com
Russian Federation, Kazan, Russia
V D Zhukova
Kazan State Medical University
Author for correspondence.
Email: valyazhu@gmail.com
Russian Federation, Kazan, Russia
A O Artemyeva
Kazan State Medical University
Email: valyazhu@gmail.com
Russian Federation, Kazan, Russia
A Yu Kazantsev
Kazan State Medical University
Email: valyazhu@gmail.com
Russian Federation, Kazan, Russia
R T Gaifutdinov
Kazan State Medical University
Email: valyazhu@gmail.com
SPIN-code: 2788-1954
Russian Federation, Kazan, Russia
References
- Shprecher D., Mehta L. The syndrome of delayed post-hypoxic leukoencephalopathy. NeuroRehabilitation. 2010; 26 (1): 65–72. PMID: 20166270.
- Zamora C.A., Nauen D., Hynecek R. Delayed posthypoxic leukoencephalopathy: a case series and review of the literature. Brain Behav. 2015; 5 (8): e00364. doi: 10.1002/brb3.364.
- Centers for Disease Control and Prevention (CDC). MMWR Morb. Mortal. Weekly Rep. 2005; 54 (2): 36–39.
- Beeskow A.B., Oberstadt M., Saur D. Delayed Post-hypoxic Leukoencephalopathy (DPHL) — An uncommon variant of hypoxic brain damage in adults. Front. Neurol. 2018; 9: 708. doi: 10.3389/fneur.2018.00708.
- Rizzuto N., Morbin M., Ferrari S. Delayed spongiform leukoencephalopathy after heroin abuse. Acta. Neuropathol. 1997; 94 (1): 87–90. doi: 10.1007/s004010050676.
- Sener R.N. Metachromatic leukodystrophy: diffusion MR imaging findings. AJNR Am. J. Neuroradiol. 2002; 23 (8): 1424–1426. PMID: 12223391.
- Gieselmann V., Krägeloh-Mann I. Metachromatic leukodystrophy — an update. Neuropediatrics. 2010; 41 (1): 1–6. doi: 10.1055/s-0030-1253412.
- Polten A., Fluharty A.L., Fluharty C.B. Molecular basis of different forms of metachromatic leukodystrophy. N. Engl. J. Med. 1991; 324: 18–22. doi: 10.1056/NEJM199101033240104.
- Ginsburg R., Romano J. Carbon monoxide encephalopathy: need for appropriate treatment. Am. J. Psychiatry. 1976; 133 (3): 317–320. doi: 10.1176/ajp.133.3.317.
- Benarroch E.E. Oligodendrocytes. Susceptibility to injury and involvement in neurologic disease. Clin. Implic. Neurosci. Res. 2009; 72 (20): 1779–1785. doi: 10.1212/WNL.0b013e3181a6b123.
- Miró Ò., Casademont J., Barrientos A. et al. Mitochondrial cytochrome c oxidase inhibition during acute carbon monoxide poisoning. Pharmacol. Toxicol. 1998; 82 (4): 199–202. doi: 10.1111/j.1600-0773.1998.tb01425.x.
- Thom S.R., Bhopale V.M., Fisher D. Delayed neuropathology after carbon monoxide poisoning is immune-mediated. Proc. Natl. Acad. Sci. USA. 2004; 101 (37): 13 660–13 665. doi: 10.1073/pnas.0405642101.
- Lee M.S., Marsden C.D. Neurological sequelae following carbon monoxide poisoning clinical course and outcome according to the clinical types and brain computed tomography scan findings. Mov. Disord. 1994; (5): 550–558. doi: 10.1002/mds.870090508.
- Geraldo A.F., Silva C., Neto L.L. et al. Delayed leukoencephalopathy after acute carbon monoxide intoxication. J. Radiol. Case Rep. 2014; 8 (5): 1–8. doi: 10.3941/jrcr.v8i5.1721.
- Choi I.S. Carbon monoxide poisoning: Systemic manifestations and complications. J. Korean Med. Sci. 2001; 16: 253–261. doi: 10.3346/jkms.2001.16.3.253.
- Ostapenko Yu.N., Zobnin Yu.V., Lezhenina N.F. Toksicheskoe deystvie okisi ugleroda. Federal`nye klinicheskie recommendatsii. (Toxic effect of carbon monoxide. Federal clinical guidelines.) Мoscow. 2013; 38 р. (In Russ.)
- Shprecher D.R., Flanigan K.M., Smith A.G. Clinical and diagnostic features of delayed hypoxic leukoencephalopathy. J. Neuropsychiatry Clin. Neurosci. 2008; 20 (4): 473–477. doi: 10.1176/appi.neuropsych.20.4.473.
- Sener R.N. Acute carbon monoxide poisoning: Diffusion MR imaging findings. Am. J. Neuroradiol. 2003; 24 (7): 1475–1477. PMID: 12917151.
- Kim D.M., Lee I.H., Park J.Y. Acute carbon monoxide poisoning: MR imaging findings with clinical correlation. Diagn. Interv. Imaging. 2017; 98 (4): 299–306. doi: 10.1016/j.diii.2016.10.004.
- Kim J.H., Chang K.H., Song I.C. Delayed encephalopathy of acute carbon monoxide intoxication: diffusivity of cerebral white matter lesions. AJNR Am. J. Neuroradiol. 2003; 24 (8): 1592–1597. PMID: 13679276.
- Beppu T. The role of MR imaging in assessment of brain damage from carbon monoxide poisoning: A review of the literature. Am. J. Neuroradiol. 2014; 35 (4): 1–7. doi: 10.3174/ajnr.A3489.
- Finelli P.F., DiMario J. MR imaging and prognosis of hypoxic-ischemic leukoencephalopathy. Neurocrit. Care. 2006; 4 (2): 119–126. doi: 10.1385/NCC:4:2:119.
- Manoj M., Wang Y., Reeves A. Methadone-induced delayed posthypoxic encephalopathy: Clinical, radiological, and pathological findings. Case Rep. Med. 2010; 716494: 1–4. doi: 10.1155/2010/716494.
- Arciniegas D.B., Frey K.L., Anderson C.A. Amantadine for neurobehavioural deficits following delayed post-hypoxic encephalopathy. Brain Inj. 2004; 18 (12): 1309–1318. doi: 10.1080/02699050410001720130.
- Price J.D., Grimley E.J. An N-of-1 randomized controlled trial ('N-of-1 trial’) of donepezil in the treatment of non-progressive amnestic syndrome. Age Ageing. 2002; 31 (4): 307–309. doi: 10.1093/ageing/31.4.307.
- Rozen T.D. Rapid resolution of akinetic mutism in delayed post-hypoxic leukoencephalopathy with intravenous magnesium sulfate. NeuroRehabilitation. 2012; 30 (4): 329–332. doi: 10.3233/NRE-2012-0763.
- Scheinkestel C.D., Bailey M., Myles P.S. Hyperbaric or normobaric oxygen for acute carbon monoxide poisoning: a randomised controlled clinical trial. Med. J. Aust. 1999; 170 (5): 203–210. doi: 10.5694/j.1326-5377.1999.tb140318.x.
- Carroll I., Heritier Barras A.-C., Dirren E. Delayed leukoencephalopathy after alprazolam and methadone overdose: A case report and review of the literature. Clin. Neurol. Neurosurg. 2012; 114 (6): 816–819. doi: 10.1016/j.clineuro.2011.12.052.
- King F., Morris N.A., Schmahmann J.D. Delayed Posthypoxic leukoencephalopathy: Improvement with antioxidant therapy. Case Rep. Neurol. 2015; 7 (3): 242–246. doi: 10.1159/000441892.
- Cocito L., Biagioli M., Fontana P. Cognitive recovery after delayed carbon monoxide encephalopathy. Clin. Neurol. Neurosurg. 2005; 107 (4): 347–350. doi: 10.1016/j.clineuro.2004.09.008.
Supplementary files
